Literature DB >> 22012131

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.

S Susan Hedayati1, Venkata Yalamanchili, Fredric O Finkelstein.   

Abstract

Depression is a common, under-recognized, and under-treated problem that is independently associated with increased morbidity and mortality in CKD patients. However, only a minority of CKD patients with depression are treated with antidepressant medications or nonpharmacologic therapy. Reasons for low treatment rates include a lack of properly controlled trials that support or refute efficacy and safety of various treatment regimens in CKD patients. The aim of this manuscript is to provide a comprehensive review of studies exploring depression treatment options in CKD. Observational studies as well as small trials suggest that certain serotonin-selective reuptake inhibitors may be safe to use in patients with advanced CKD and ESRD. These studies were limited by small sample sizes, lack of placebo control, and lack of formal assessment for depression diagnosis. Nonpharmacologic treatments were explored in selected ESRD samples. The most promising data were reported for frequent hemodialysis and cognitive behavioral therapy. Alternative proposed therapies include exercise training regimens, treatment of anxiety, and music therapy. Given the association of depression with cardiovascular events and mortality, and the excessive rates of cardiovascular death in CKD, it becomes imperative to not only investigate whether treatment of depression is efficacious, but also whether it would result in a reduction in morbidity and mortality in this patient population.

Entities:  

Mesh:

Year:  2011        PMID: 22012131      PMCID: PMC3258342          DOI: 10.1038/ki.2011.358

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  70 in total

1.  Improving psychosocial health in hemodialysis patients after a disaster.

Authors:  Sheila Weiner; Nancy G Kutner; Tess Bowles; Stephanie Johnstone
Journal:  Soc Work Health Care       Date:  2010

2.  Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

Authors:  Stephen Tyring; Alice Gottlieb; Kim Papp; Ken Gordon; Craig Leonardi; Andrea Wang; Deepa Lalla; Michael Woolley; Angelika Jahreis; Ralph Zitnik; David Cella; Ranga Krishnan
Journal:  Lancet       Date:  2006-01-07       Impact factor: 79.321

3.  In-center hemodialysis six times per week versus three times per week.

Authors:  Glenn M Chertow; Nathan W Levin; Gerald J Beck; Thomas A Depner; Paul W Eggers; Jennifer J Gassman; Irina Gorodetskaya; Tom Greene; Sam James; Brett Larive; Robert M Lindsay; Ravindra L Mehta; Brent Miller; Daniel B Ornt; Sanjay Rajagopalan; Anjay Rastogi; Michael V Rocco; Brigitte Schiller; Olga Sergeyeva; Gerald Schulman; George O Ting; Mark L Unruh; Robert A Star; Alan S Kliger
Journal:  N Engl J Med       Date:  2010-11-20       Impact factor: 91.245

4.  Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk.

Authors:  Rebecca A Drayer; Beth Piraino; Charles F Reynolds; Patricia R Houck; Sati Mazumdar; Judith Bernardini; M Katherine Shear; Bruce L Rollman
Journal:  Gen Hosp Psychiatry       Date:  2006 Jul-Aug       Impact factor: 3.238

5.  Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study.

Authors:  Bertrand L Jaber; Yoojin Lee; Allan J Collins; Alan R Hull; Michael A Kraus; James McCarthy; Brent W Miller; Les Spry; Fredric O Finkelstein
Journal:  Am J Kidney Dis       Date:  2010-07-29       Impact factor: 8.860

6.  Validation of 2 depression screening tools in dialysis patients.

Authors:  Suzanne Watnick; Pei-Li Wang; Theresa Demadura; Linda Ganzini
Journal:  Am J Kidney Dis       Date:  2005-11       Impact factor: 8.860

7.  Treatment with antidepressive drugs improved quality of life in chronic hemodialysis patients.

Authors:  S Turk; H Atalay; L Altintepe; I Güney; N Okudan; H Z Tonbul; H Gökbel; R Kücür; M Yeksan; A Yildiz
Journal:  Clin Nephrol       Date:  2006-02       Impact factor: 0.975

8.  The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients.

Authors:  S S Hedayati; H B Bosworth; M Kuchibhatla; P L Kimmel; L A Szczech
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

9.  Methodology of a randomized clinical trial of symptom management strategies in patients receiving chronic hemodialysis: the SMILE study.

Authors:  Steven D Weisbord; Anne Marie Shields; Maria K Mor; Mary Ann Sevick; Marcia Homer; Janet Peternel; Patricia Porter; Bruce L Rollman; Paul M Palevsky; Robert M Arnold; Michael J Fine
Journal:  Contemp Clin Trials       Date:  2010-07-01       Impact factor: 2.226

10.  The clinical effects of music therapy in palliative medicine.

Authors:  Lisa M Gallagher; Ruth Lagman; Declan Walsh; Mellar P Davis; Susan B Legrand
Journal:  Support Care Cancer       Date:  2006-03-15       Impact factor: 3.603

View more
  77 in total

1.  Patterns and predictors of depression treatment among adults with chronic kidney disease and depression in ambulatory care settings in the United States.

Authors:  Nina Vadiei; Sandipan Bhattacharjee
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

2.  ASCENDing to New Heights in Our Understanding of the Treatment of Depression Among Individuals Receiving Hemodialysis.

Authors:  Jennifer E Flythe
Journal:  Ann Intern Med       Date:  2019-02-26       Impact factor: 25.391

3.  Standards of clinical practice for renal pharmacists.

Authors:  Colette B Raymond; Lori D Wazny; Amy R Sood
Journal:  Can J Hosp Pharm       Date:  2013-11

4.  The cross-lagged association between depressive symptoms and health-related quality of life in patients receiving maintenance hemodialysis: a three-wave longitudinal study.

Authors:  Jieling Chen; Lingling Liu; Jing Chen; Marques S N Ng; Vivian W Q Lou; Bibo Wu; Weijie Jiang; Yanqing Jie; Jingfen Zhu; Yaping He
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

5.  Depressive symptom severity, contributing factors, and self-management among chronic dialysis patients.

Authors:  Mi-Kyung Song; Sandra E Ward; Gerald A Hladik; Jessica C Bridgman; Constance A Gilet
Journal:  Hemodial Int       Date:  2015-05-21       Impact factor: 1.812

6.  Indicators and correlates of psychological disturbance in Chinese patients receiving maintenance hemodialysis: a cross-sectional study.

Authors:  Si-Yuan Wang; Xiao-Ying Zang; Jun-Duo Liu; Mei Cheng; Yue-Xian Shi; Yue Zhao
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

Review 7.  Exercise interventions improve depression and anxiety in chronic kidney disease patients: a systematic review and meta-analysis.

Authors:  Thalita Lauanna Ferreira; Heitor Siqueira Ribeiro; Alexandre Lima Araújo Ribeiro; Ana Clara Bonini-Rocha; Joana Marcela Sales Lucena; Poliana Alves de Oliveira; Francisco Rafael S Amorim; Aparecido Pimentel Ferreira; Luiz Alexandre Viana Magno; Wagner Rodrigues Martins
Journal:  Int Urol Nephrol       Date:  2020-08-31       Impact factor: 2.370

Review 8.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

Review 9.  Management of anxiety and depression in haemodialysis patients: the role of non-pharmacological methods.

Authors:  G Gerogianni; F Babatsikou; M Polikandrioti; E Grapsa
Journal:  Int Urol Nephrol       Date:  2018-11-19       Impact factor: 2.370

10.  Depression and all-cause mortality in hemodialysis patients.

Authors:  Li Fan; Mark J Sarnak; Hocine Tighiouart; David A Drew; Amy L Kantor; Kristina V Lou; Kamran Shaffi; Tammy M Scott; Daniel E Weiner
Journal:  Am J Nephrol       Date:  2014-06-24       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.